Articles with public access mandates - John Strang - Wellcome TrustLearn more
NoteFor this mandate, articles should be available from specific locations.
Not available based on mandate: 3
Heroin‐induced respiratory depression and the influence of dose variation: within‐subject between‐session changes following dose reduction
B Tas, CJ Jolley, NJ Kalk, R van der Waal, J Bell, J Strang
Addiction 115 (10), 1954-1959, 2020
Open letter from UK based academic scientists to the secretaries of state for digital, culture, media and sport and for health and social care regarding the need for …
H Wardle, J Banks, P Bebbington, L Blank, HBJ Obe, S Bramley, C Bunn, ...
bmj 370, 2020
Phenotypic heterogeneity in study populations may significantly confound the results of genetic association studies on alcohol dependence
MA Ali, MJ Way, M Marks, I Guerrini, AD Thomson, J Strang, A McQuillin, ...
Psychiatric genetics 25 (6), 234-240, 2015
Available based on mandate: 12
Cannabidiol does not attenuate acute delta‐9‐tetrahydrocannabinol‐induced attentional bias in healthy volunteers: A randomised, double‐blind, cross‐over study
D Oliver, A Englund, E Chesney, L Chester, J Wilson, S Sovi, S Wigroth, ...
Addiction 119 (2), 322-333, 2024
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD: THC ratios
A Englund, D Oliver, E Chesney, L Chester, J Wilson, S Sovi, A De Micheli, ...
Neuropsychopharmacology 48 (6), 869-876, 2023
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England
D Aldabergenov, L Reynolds, J Scott, MJ Kelleher, J Strang, ...
International Journal of Drug Policy 110, 103877, 2022
Could COVID expand the future of addiction research? Long‐term implications in the pandemic era
A Englund, S Sharman, B Tas, J Strang
Addiction 117 (8), 2135-2140, 2022
Abuse‐deterrent extended‐release oxycodone and risk of opioid‐related harm
T Paljarvi, J Strang, PD Quinn, S Luciano, S Fazel
Addiction 116 (9), 2409-2415, 2021
Pharmacological treatment of mood disorders and comorbid addictions: a systematic review and meta-analysis: traitement pharmacologique des troubles de l’humeur et des …
PRA Stokes, T Jokinen, S Amawi, M Qureshi, MI Husain, LN Yatham, ...
The Canadian Journal of Psychiatry 65 (11), 749-769, 2020
Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: exploratory mixed methods analysis
J Neale, NJ Kalk, S Parkin, C Brown, L Brandt, ANC Campbell, F Castillo, ...
Journal of substance abuse treatment 117, 108099, 2020
Incidence and treatment costs of severe bacterial infections among people who inject heroin: a cohort study in South London, England
D Lewer, VD Hope, M Harris, M Kelleher, A Jewell, M Pritchard, J Strang, ...
Drug and alcohol dependence 212, 108057, 2020
Development and early validation of a patient-reported outcome measure to assess sleep amongst people experiencing problems with alcohol or other drugs
J Neale, S Vitoratou, P Lennon, R Meadows, S Nettleton, D Panebianco, ...
Sleep 41 (4), zsy013, 2018
Memory-focused cognitive therapy for cocaine use disorder: theory, procedures and preliminary evidence from an external pilot randomised controlled trial
J Marsden, C Goetz, T Meynen, L Mitcheson, G Stillwell, B Eastwood, ...
EBioMedicine 29, 177-189, 2018
Memory-focused cognitive therapy for cocaine use disorder: rationale, design and protocol for an external pilot randomised controlled trial
J Marsden, C Goetz, T Meynen, L Mitcheson, G Stillwell, B Eastwood, ...
Contemporary Clinical Trials Communications 8, 264-273, 2017
Alcohol harm reduction: corporate capture of a key concept
J McCambridge, K Kypri, C Drummond, J Strang
PLoS Medicine 11 (12), e1001767, 2014
Publication and funding information is determined automatically by a computer program